# A Study of Curcumin (Soloways ™) in Patients With Inflammatory Bowel Disease Homozygous for the IL-10 Variant

> **NCT06867939** · NA · COMPLETED · sponsor: **S.LAB (SOLOWAYS)** · enrollment: 40 (actual)

## Conditions studied

- Inflamatory Bowel Disease

## Interventions

- **DIETARY_SUPPLEMENT:** liposomal curcumin
- **DIETARY_SUPPLEMENT:** Liposomal Curcumin

## Key facts

- **NCT ID:** NCT06867939
- **Lead sponsor:** S.LAB (SOLOWAYS)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-05
- **Primary completion:** 2024-09-20
- **Final completion:** 2025-02-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06867939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06867939, "A Study of Curcumin (Soloways ™) in Patients With Inflammatory Bowel Disease Homozygous for the IL-10 Variant". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT06867939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*